Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.951
-0.029 (-2.97%)
Dec 20, 2024, 4:00 PM EST - Market closed
CNTB Employees
Connect Biopharma Holdings had 81 employees as of December 31, 2023. The number of employees decreased by 19 or -19.00% compared to the previous year.
Employees
81
Change (1Y)
-19
Growth (1Y)
-19.00%
Revenue / Employee
$297,728
Profits / Employee
-$263,951
Market Cap
52.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareCloud | 3,600 |
| Repare Therapeutics | 179 |
| Mural Oncology | 117 |
| VolitionRx | 110 |
| Boundless Bio | 72 |
| Kronos Bio | 63 |
| Spero Therapeutics | 46 |
| Elicio Therapeutics | 32 |
CNTB News
- 2 months ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire
- 2 months ago - CNTB Stock Dips Amid Biotech Sector Volatility - GuruFocus
- 2 months ago - CNTB Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus
- 3 months ago - Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewsWire
- 6 months ago - Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Connect Biopharma Announces New Leadership and Chair of the Board of Directors - GlobeNewsWire
- 7 months ago - Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma - GlobeNewsWire